Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Infosys Ltd. Interim / Quarterly Report 2016

Jan 14, 2016

17843_rns_2016-01-14_bdd17b45-6abf-4f28-ba08-802e556ecbc0.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

Infosys Limited

CIN: L85110XA1981PLC013115

Regd. Office: Electronics City, Hosur Road, Bangalore - 560 100, India.

Website: www.infosys.com; email: [email protected]; T: 91 80 2852 0261; F: 91 93 2852 0362

Audited financial results of Infosys Limited for the quarter and nine months ended December 31, 2015. (in € crore, except equity share and per equity share data)

Particulars Quarter ended December 31, Quarter ended September 30, Quarter ended December 31, Nine months ended December 31, Year ended March 31,
2015 2015 2014 2015 2014 2015
Income from software services and products 13,502 13,525 12,152 35,928 35,374 47,300
Expenses: - - - - - -
Employee benefit expenses 7,103 6,986 6,368 20,908 18,932 25,115
Deferred consideration pertaining to acquisition 18 46 55 110 168 219
Cost of technical sub-contractors 1,226 1,035 777 3,225 2,073 2,909
Travel expenses 360 425 329 1,217 1,035 1,360
Cost of software packages and others 200 335 290 826 755 979
Communication expenses 73 80 116 232 294 384
Consultancy and professional charges 153 123 114 406 248 398
Depreciation and amortization expense 279 272 229 799 672 913
Other expenses 515 423 495 1,388 1,428 1,975
Total expenses 9,822 9,724 8,763 29,110 25,604 34,251
Profit from operations before other income 3,528 3,881 3,429 10,715 9,770 13,049
Other income 737 774 823 2,230 2,446 3,337
Profit before exceptional item and tax 4,376 4,875 4,252 12,948 12,216 16,386
Profit on transfer of business(1) - 3,036 - 3,038 412 412
Profit before tax 4,376 7,611 4,252 15,951 12,628 16,795
Tax expense 1,193 1,305 1,197 3,594 3,488 4,834
Net Profit for the period 3,103 6,306 3,035 12,387 9,140 12,164
Paid-up equity share capital (per value ₹5/- each fully paid)(2) 1,148 1,148 572 1,148 572 574
Reserves and surplus 47,404 47,404 41,806 47,494 41,806 47,494
Earnings per share (per value ₹5/- each)3
Before exceptional item
Basic 13.86 14.24 13.37 40.71 38.19 51.17
Diluted 13.86 14.24 13.37 40.71 38.19 51.17
After exceptional item
Basic 13.88 27.45 13.37 53.93 39.99 52.98
Diluted 13.88 27.45 13.37 53.93 39.99 52.98

(1) Exceptional item pertains to profit on transfer of business to EdgeVerve, a wholly owned subsidiary. (2) net of treasury shares as at December 31, 2014 3 adjusted for bonus issues wherever applicable

Notes:

  1. The audited financial statements for the quarter and nine months ended December 31, 2015 have been taken on record by the Board of Directors at its meeting held on January 14, 2016. The statutory auditors have expressed an unqualified audit opinion. The information presented above is extracted from the audited standalone financial statements.

2. Changes to the Board

i. On January 14, 2016, the Board appointed Dr. Purita Kumar Sinha as an independent director with immediate effect.

ii. Ms. Carol M. Browner resigned as member of the Board effective November 23, 2015. The Board placed on record its deep sense of appreciation for the services rendered by her during her tenure as a director.

iii. The Board recommended the re-appointment of Prof. Jeffrey S. Lehman, Independent Director of the Company for a term of two years with effect from April 14, 2016 to hold office up to April 13, 2018, and not be liable to retire by rotation. Prof. Lehman's current term of office as an independent Director expires on April 13, 2016. The appointment is subject to the approval of the shareholders.

3. Investments

On November 16, 2015, Infosys has acquired 100% membership interest in Noah Consulting, LLC (Noah), a leading provider of advanced information management consulting services for the oil and gas industry. The business acquisition was conducted by entering into a share purchase agreement for cash consideration of $33 million (approximately ₹216 crore), contingent consideration of up to $5 million (approximately ₹35 crore) and an additional payout of up to $32 million (approximately ₹212 crore).

4. Information on dividends for the quarter and nine month ended December 31, 2015

An interim dividend of ₹10/- (per value ₹5/- each) per equity share was declared on October 12, 2016 and paid on October 21, 2015. The interim dividend declared in the previous year was ₹30/- (not adjusted for bonus issues) per equity share.

(in €)

Particulars Quarter ended December 31, Quarter ended September 30, Quarter ended December 31, Nine months ended December 31, Year ended March 31,
2015 2015 2014 2015 2014 2015
Dividend per share (per value ₹5/- each)
Interim dividend - 10.00 - 10.00 30.00(1) 30.00(1)
Final dividend - - - - - 29.00(2)

(1) not adjusted for bonus issues on December 3, 2014 and June 17, 2015 (2) not adjusted for bonus issue on June 17, 2015


  1. Segment reporting (Standalone-Audited)

(in F score)

Particulars Quarter ended December 31, Quarter ended September 30, Quarter ended December 31, Nine months ended December 31, Year ended March 31,
2015 2016 2014 2015 2014 2015
Revenue by industry segment
Financial Services and Insurance (FSI) 4,468 4,418 4,161 13,239 12,049 16,175
Manufacturing (MFG) 2,990 3,123 2,620 8,981 7,598 10,230
Energy & utilities, Communication and Services (ECS) 2,803 2,693 2,558 7,967 7,379 9,758
Retail, Consumer Packaged Goods and Logistics (RCL) 2,379 2,399 2,113 6,975 6,272 8,369
Life Sciences and Healthcare (LSH) 922 922 742 2,683 2,078 2,770
Total 13,562 13,525 12,192 35,625 35,374 47,300
Less: Inter-segment revenue
Net revenue from operations 13,562 13,525 12,192 35,625 35,374 47,300
Segment profit before tax and depreciation
Financial Services and Insurance (FSI) 1,251 1,316 1,285 3,803 3,637 4,905
Manufacturing (MFG) 875 884 708 2,502 2,103 2,798
Energy & utilities, Communication and Services (ECS) 847 882 799 2,414 2,197 2,920
Retail, Consumer Packaged Goods and Logistics (RCL) 715 717 664 2,073 1,994 2,620
Life Sciences and Healthcare (LSH) 231 274 212 722 551 723
Total 3,914 4,573 3,658 11,514 10,442 13,966
Less: Other unallocable expenditure 275 272 229 799 672 917
Add: Unallocable other income 737 774 823 2,230 2,446 3,337
Profit before exceptional item and tax 4,378 4,575 4,252 12,945 12,218 16,386
Exceptional item(1) - 3,036 - 3,036 412 412
Profit before tax 4,378 7,611 4,252 15,951 12,628 16,790

(1) Exceptional item pertains to profit on transfer of business to EdgeVerve, a wholly owned subsidiary.

Notes on segment information:

Primary segments

The Company's operations predominantly relate to providing end-to-end business solutions to enable clients to enhance business performance. Revenues represented along industries served constitute the primary basis of the segmental information set out above. Effective April 1, 2015, the Company reorganized its segments to support its objective of delivery innovation. This structure will help deliver services that will reflect the way technology is consumed in layers by the client's enterprise. However the reorganization did not have any impact in the reportable segments as per Accounting Standard 17 'Segment reporting'.

Segmental capital employed

Assets and liabilities used in the company's business are not identified to any of the reportable segments, as these are used interchangeably between segments. The Management believes that it is not practicable to provide segment disclosures relating to total assets and liabilities since a meaningful segregation of the available data is onerous.

Bangalore, India

January 14, 2016

By order of the Board

for Infosys Limited

Dr. Vishal Sikka

Chief Executive Officer and Managing Director

Certain statements in this release concerning our future growth prospects are forward-looking statements regarding our future business expectations intended to qualify for the 'safe harbor' under the Private Securities Litigation Reform Act of 1995, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in earnings, fluctuations in foreign exchange rates, our ability to manage growth, intense competition in IT services including those factors which may affect our cost advantage, wage increases in India, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, industry segment concentration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks or system failures, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, the success of the companies in which Infosys has made strategic investments, withdrawal or expiration of governmental fiscal incentives, political instability and regional conflicts, legal restrictions on raising capital or acquiring companies outside India, and unauthorized use of our intellectual property and general economic conditions affecting our industry. Additional risks that could affect our future operating results are more fully described in our United States Securities and Exchange Commission filings including our Annual Report on Form 30-F for the fiscal year ended March 31, 2015. These filings are available at www.sec.gov. Infosys may, from time to time, make additional written and oral forward-looking statements, including statements contained in the company's filings with the Securities and Exchange Commission and our reports to shareholders. In addition, please note that the date of this release is January 14, 2016, and any forward-looking statements contained herein are based on assumptions that we believe to be reasonable as of this date. The company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the company unless it is required by law.